Hydrogen peroxide mediates FK506-induced cytotoxicity in renal cells

Kidney International

Volumn 65, Issue 1, 2004, Pages 139-147

  Zhou, Xiaoming ^a   Yang, Guang ^b   Davis, Christopher A ^b   Doi, Sonia Q ^b   Hirszel, Przemyslaw ^b   Wingo, Charles S ^b   Agarwal, Anupam ^b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NONE

Author keywords

And MnSOD; Catalase; Cell death; FK506; HEK293 cells; Hydrogen peroxide; LLC PK1 cells; Reactive oxygen species

Indexed keywords

BENZOIC ACID; CATALASE; CRYSTAL VIOLET; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; TACROLIMUS; TIRON;

ARTICLE; CELL DEATH; CELL PROTECTION; CYTOTOXICITY; DETOXIFICATION; DRUG INDUCED DISEASE; FENTON REACTION; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; NEPHROTOXICITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION;

EID: 0347992787     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00380.x     Document Type: Article

References (35)

1. TOCCI MJ, MATKOVICH DA, COLLIER KA, et al: The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 143:718-726, 1989
2. HENRY ML: Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profiles. Clin Transplant 13:209-220, 1999
3. DE MATTOS AM, OLYAEI AJ, BENNETT WM: Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future. Am J Kidney Dis 35:333-346, 2000
4. GONIN, JM: Maintenance immunosuppression: New agents and persistent dilemmas. Adv Ren Replace Ther 7:95-116, 2000
5. HEALY E, DEMPSEY M, LALLY C, et al: Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line. Kidney Int 54:1955-1966, 1998
6. THOMAS SE, ANDOH TF, PICHLER RH, et al: Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 53:897-908, 1998
7. BALIGA R, UEDA N, WALKER PD, et al: Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 31:971-997, 1999
8. NISHIDA M, OGAWA H, TAMAI M, et al: Role of hydrogen peroxide in cyclosporine-induced renal tubular cell (LLC-PK1) injury. J Pharmacol Sci 91:255-258, 2003
9. DURAK I, KARABACAK HI, BUYUKKOCAK S, et al: Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron 78:207-211, 1998
10. TADA H, NAKASHIMA A, AWAYA A, et al: Effects of thymic hormone on reactive oxygen species-scavengers and renal function in tacrolimus-induced nephrotoxicity. Life Sci 70:1213-1223, 2002
11. WANG CY, MAYO MW, BALDWIN AS JR: TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB. Science 274:784-787, 1996
12. ZHAO A, WU ZQ, POLLACK M, et al: Disulfiram inhibits TNF-alpha-induced cell death. Cytokine 12:1356-1367, 2000
13. DAVIS CA, NICK HS, AGARWAL A: Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: Importance of superoxide. J Am Soc Nephrol 12:2683-2690, 2001
14. BROCKMAN JA, SCHERER DC, MCKINSEY TA, et al: Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol 15:2809-2818, 1995
15. KLAHR S, MORRISSEY J: Progression of chronic renal disease. Am J Kidney Dis 41(3 Suppl 2):S3-S7, 2003
16. ZHOU X, ZHAO A, GOPING G, et al: Gliotoxin-induced cytotoxicity proceeds via apoptosis and is mediated by caspases and reactive oxygen species in LLC-PK1 cells. Toxicol Sci 54:194-202, 2000
17. KRISHNA MC, RUSSO A, MITCHELL JB, et al: Do nitroxide antioxidants act as scavengers of superoxide anion or as SOD mimics? J Biol Chem 271:26026-26031, 1996
18. DJAVAHERI-MERGNY M, WIETZERBIN J, BESANCON F: 2-Methoxyestradiol induces apoptosis in Ewing sarcoma cells through mitochondrial hydrogen peroxide production. Oncogene 22:2558-2567, 2003
19. FUJITA T, MARUYAMA M, ARAYA J, et al: Hydrogen peroxide induces upregulation of Fas in human airway epithelial cells via the activation of PARP-p53 pathway. Am J Respir Cell Mol Biol 27:542-552, 2002
20. QUILLET-MARY A, JAFFREZOU JP, MANSAT V, et al: Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 272:21388-21395, 1997
21. ZINI R, SIMON N, MORIN C, et al: Tacrolimus decreases in vitro oxidative phosphorylation of mitochondria from rat forebrain. Life Sci 63:357-368, 1998
22. ZHONG Z, CONNOR HD, YIN M, et al: Dietary glycine and renal denervation prevents cyclosporin A-induced hydroxyl radical production in rat kidney. Mol Pharmacol 56:455-463, 1999
23. TANAKA K, FUJITA N, YOSHIOKA M, et al: Immunosuppressive and non-immunosuppressive immunophilin ligands improve H(2)O(2)-induced cell damage by increasing glutathione levels in NG108-15 cells. Brain Res 889:225-228, 2001
24. BAI J, CEDERBAUM AI: Catalase protects HepG2 cells from apoptosis induced by DNA-damaging agents by accelerating the degradation of p 53. J Biol Chem 278:4660-4667, 2003
25. MARI M, BAI J, CEDERBAUM AI: Adenovirus-mediated overexpression of catalase in the cytosolic or mitochondrial compartment protects against toxicity caused by glutathione depletion in HepG2 cells expressing CYP2E1. J Pharmacol Exp Ther 301:111-118, 2002
26. MORENO-MANZANO V, ISHIKAWA Y, LUCIO-CAZANA J, et al: Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-alpha-induced apoptosis of rat mesangial cells. J Biol Chem 275:12684-12691, 2000
27. WONG GH, ELWELL JH, OBERLEY LW, et al: Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923-931, 1989
28. BAI J, CEDERBAUM AI: Overexpression of catalase in the mitochondrial or cytosolic compartment increases sensitivity of HepG2 cells to tumor necrosis factor-alpha-induced apoptosis. J Biol Chem 275:19241-19249, 2000
29. HIGGINS RM, HART P, LAM FT, et al: Conversion from tacrolimus to cyclosporin in stable renal transplant patients: Safety, metabolic changes, and pharmacokinetic comparison. Transplantation 70:199-202, 2000
30. TEXTOR SC, WIESNER R, WILSON DJ, et al: Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant. Transplantation 55:1332-1339, 1993
31. ELLOUK-ACHARD S, MARTIN C, PHAM-HUY C, et al: Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture. Arch Toxicol 71:437-442, 1997
32. AHMED SS, STROBEL HW, NAPOLI KL, GREVEL J: Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes. J Pharmacol Exp Ther 265:1047-1054, 1993
33. HEBERER M, JORGENSEN J, MIHATSCH MJ, et al: Protective effect of allopurinol and superoxide dismutase in renal isografts in cyclosporin A-treated rats. Renal Failure 13:233-242, 1991
34. WOLF A, CLEMANN N, FRIEAUFF W, et al: Role of reactive oxygen formation in the cyclosporin-A-mediated impairment of renal functions. Transplant Proc 26:2902-2907, 1994
35. KOCHI S, TAKANAGA H, MATSUO H, et al: Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus. Life Sci 66:2255-2260, 2000